March 4, 2024

Press Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment

October 10, 2023

The Fall 2023 advocacy blog Considering Clinical Trials is now available

July 20, 2023

Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative

June 16, 2023

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 31, 2023

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

March 23, 2023

The Spring 2023 advocacy blog Considering Clinical Trials is now available

February 10, 2023

The January/February 2023 News from ECOG-ACRIN blog is now available

December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group